Jo Paladino, MD is a Palliative Care physician on faculty at the Dana-Farber Cancer Institute and Ariadne Labs. Jo earned her B.A. from Boston University and M.D from Weill Medical College of Cornell University. In her current role, Jo coordinates the implementation efforts for the Serious Illness Care randomized trial in ten disease centers and two satellite locations at the Dana-Farber Cancer Institute. In addition, Jo’s work on implementation and strategy supports the expansion of the Serious Illness Care Program to achieve successful spread to additional healthcare settings. Jo also works on curriculum development to train colleagues of all disciplines in serious illness communication.
Jo completed her internship and residency training in Primary Care and Population Medicine at Brigham and Women’s Hospital. She completed her fellowship training in Palliative Care at Harvard’s Interdisciplinary Palliative Care Fellowship at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Massachusetts General Hospital. She is board certified in Internal Medicine and Hospice and Palliative Medicine.
Drs. Juliet Jacobson, Rachelle Bernacki, and Jo Paladino pen a JAMA Viewpoint on serious illness communication.
Dr. Jo Paladino in Kaiser Health News on the shift from advanced care planning to having conversations with people about making complicated decisions when they become seriously ill.
Fifteen U.S. health systems are collaborating with Ariadne Labs to initiate more, better, and earlier conversations with seriously ill patients as part of an innovative collaborative that is reaching diverse populations from coast to coast. The Serious Illness Implementation Collaborative – which offers trainings offered in partnership with Ariadne Labs, the Center to Advance Palliative… Continue reading Ariadne partners with health systems to initiate serious illness conversation programs
A new viewpoint written by palliative care experts at Ariadne Labs and published in the Journal of the American Medical Association (JAMA) highlights key strategies for communicating prognosis with patients. The viewpoint discusses the challenges associated with delivering difficult news to patients and how not receiving this information can create patient anxiety and distance them… Continue reading New viewpoint highlights strategies for communicating prognosis with patients